Article
Modifier effect of the Toll-like receptor 4 D299G polymorphism in children with cystic fibrosis.
Archivum immunologiae et therapiae experimentalis - 1 Jan 2000
Urquhart Donald S, Allen Jennifer, Elrayess Mohamed, Fidler Katy, Klein Nigel, Jaffé Adam
Abstract excerpt
INTRODUCTION: Clinical phenotype varies amongst cystic fibrosis (CF) patients with identical CF transmembrane regulator (CFTR) genotype, suggesting genetic modifiers exist. One potential modifier is the Toll-like receptor 4 (TLR4) gene. TLR4 binds lipopolysaccharide (LPS), a constituent of Pseudomonas aeruginosa (PA), activating innate immunity and promoting inflammation. TLR4 polymorphisms are associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
